{
    "clinical_study": {
        "@rank": "115880", 
        "arm_group": [
            {
                "arm_group_label": "Telemonitoring assisted self-care", 
                "arm_group_type": "Active Comparator", 
                "description": "Telemonitoring assisted self-care group was given a home-care package including a weight scale, a blood pressure meter, a mobile phone and self-care instructions.  A pre-installed software application in the mobile phone supported uploading of measurements and self-assessment of symptoms. The patients were advised to carry out and report the measurements together with the self-assessment once a week."
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "No Intervention", 
                "description": "Control group received usual care"
            }
        ], 
        "brief_summary": {
            "textblock": "In the study benefits of using mobile phone assisted remote patient monitoring including\n      self-measurements of blood pressure, heart rate and weight as well as monitoring of personal\n      health status are investigated in the care of heart failure patients."
        }, 
        "brief_title": "Heart at Home- a Self-care Study", 
        "completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Diagnosis of systolic heart failure , NYHA (New York Heart Association) classification >\n        1, left ventricular ejection fraction \u2264 35%, need for a regular control visit, time from\n        the last visit no longer than 6 months\n\n        Exclusion Criteria:\n\n        Patients who were known to enter a major medical operation, had severe comorbidity,, had\n        participated in other clinical trial during last three months or were suspected of poor\n        compliance were excluded in the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "19 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "94", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01759368", 
            "org_study_id": "HUSHAH"
        }, 
        "intervention": {
            "arm_group_label": "Telemonitoring assisted self-care", 
            "description": "The responsible nurse followed patients' status and the data once a week or more frequently if needed. Based on the reported measurements, the nurse could invite the patient for a control visit.  In case a patient did not make self-measurements as planned , the nurse contacted the patient and reminded him/ her to continue with monitoring.", 
            "intervention_name": "Telemonitoring assisted self-care", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "self-care, heart failure, telemonitoring, health care utilization", 
        "lastchanged_date": "December 30, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Espoo", 
                    "country": "Finland"
                }, 
                "name": "VTT Technical Research Centre of Finland"
            }
        }, 
        "location_countries": {
            "country": "Finland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Heart at Home- Remote Patient Monitoring in the Care of Heart Failure Patients", 
        "other_outcome": [
            {
                "description": "Change in plasma concentrations of creatinine, natrium, and  potassium from the baseline to seven months.", 
                "measure": "laboratory test", 
                "safety_issue": "No", 
                "time_frame": "Study period of seven months on average"
            }, 
            {
                "description": "Change in left ventricular ejection fraction from baseline to seven months.", 
                "measure": "left ventricular ejection fraction", 
                "safety_issue": "No", 
                "time_frame": "Study period of seven months on average"
            }, 
            {
                "description": "number of visits at physician, number of visits at nurse, phone contacts with nurse, unplanned visits at nurse, unplanned visits at physician", 
                "measure": "Utilization of health care resources", 
                "safety_issue": "No", 
                "time_frame": "Study period of seven months on average"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Number of hospital days at the Cardiology Clinic.", 
            "measure": "Number of hospital days", 
            "safety_issue": "No", 
            "time_frame": "study period of seven months on average"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01759368"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Death from any cause", 
                "measure": "Death", 
                "safety_issue": "No", 
                "time_frame": "Study period of seven months on average"
            }, 
            {
                "description": "Heart transplant operation or listing for transplant operation", 
                "measure": "Heart transplant", 
                "safety_issue": "No", 
                "time_frame": "Study period of seven months on average"
            }, 
            {
                "description": "Change in plasma concentration of brain natriuretic peptide propeptide from baseline to seven months.", 
                "measure": "P-proBNP", 
                "safety_issue": "No", 
                "time_frame": "Study period of seven months on average"
            }, 
            {
                "description": "Change from baseline to seven months in self-care behaviour measured by the European Heart Failure Self-Care Behaviour Scale", 
                "measure": "EHFSBS (European Heart Failure Self-Care Behaviour Scale ) scores", 
                "safety_issue": "No", 
                "time_frame": "Study period of seven months on average"
            }
        ], 
        "source": "VTT Technical Research Centre of Finland", 
        "sponsors": {
            "collaborator": {
                "agency": "Helsinki University Central Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "VTT Technical Research Centre of Finland", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2010", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}